JulieAlexK The European Commission has accepted commitments by Apple (NASDAQ:AAPL) to give access to the ‘tap and go’ technology on iPhones. The agency has made commitments offered by Apple legally binding under the EU antitrust rules. The Commission said that the commitments address its competition concerns related to Apple’s refusalContinue Reading
Waldemarus Roche (OTCQX:RHHBY) unit Genentech announced Friday that the U.S. Food and Drug Administration (FDA) approved a new ready-to-use format for its eye disease therapy Vabysmo to treat three leading causes of vision loss. Accordingly, the bispecific antibody, also known as faricimab, will be available in a new format forContinue Reading
Pixelbizz/iStock Editorial via Getty Images The Netherlands’ Council of State ruled that ASML (NASDAQ:ASML) can continue expansion at its headquarters in Veldhoven, rejecting objections from two neighbors, Reuters reported. The country’s highest administrative court noted that complaints that the new facilities would lead to issues of traffic and noise wereContinue Reading
IvelinRadkov Sanofi (NASDAQ:SNY) and its partner Regeneron (NASDAQ:REGN) announced Wednesday that the EU drug regulator, the European Medicines Agency (EMA), has approved a label expansion for their asthma therapy Dupixent to include patients with the lung disorder, chronic obstructive pulmonary disease (COPD). The approval marks the first time a globalContinue Reading
Genmab (GMAB) and partner AbbVie (NYSE:ABBV) have received U.S. FDA approval for their monoclonal antibody Epkinly (epcoritamab-bysp) for the treatment of adults with relapsed or refractory follicular lymphoma. The approval is based on results from Phase 1/2 EPCORE NHL-1 study, which demonstrated durable, clinically meaningful treatment responses in patients withContinue Reading
